Cannabidiol (CBD) Clinical Trials

4 actively recruiting trials across 3 locations

Also known as: CBD capsules, Cannabidiol, Epidiolex, Epidiolex® 100 mg/mL solution, hemp-derived cannabidiol

Pipeline

Early 1: 1Phase 2: 2Phase 2/3: 1

Top Sponsors

Tiffany J. Braley, MD, MS1
Steven E Harte, PhD1
NYU Langone Health1
Fox Chase Cancer Center1

Indications

Arthritis2
Knee Arthritis1
Osteoarthritis of the Knee1
Osteoarthritis, Knee1
Oxaliplatin Induced Peripheral Neuropathy in Cancer Patients1

Ann Arbor, Michigan2 trials

Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee

University of Michigan

Phase 2

Mechanisms of Cannabidiol in Persons With MS: the Role of Sleep and Pain Phenotype

University of Michigan

Phase 2

New York, New York1 trial

Cannabidiol (CBD) in Pain Reduction for Knee Osteoarthritis

NYU Langone Health

Phase 2/3

Philadelphia, Pennsylvania1 trial

Neuroprotective Potential of Cannabidiol (CBD) in Preventing Oxaliplatin (Ox)-Induced Neuropathy

Fox Chase Cancer Center

Early 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.